top of page
Untitled design (1).png

Cardiovascular Risk Outcomes Study

For overweight adults

Clinical trial evaluating the efficacy of an oral medication in adults who are overweight.

This medication may help improve morbidity and mortality in individuals who are overweight.

Our physicians at Eastside Clinical Research have partnered with a sponsor to study the effectiveness of an oral medication on the overall health and longevity of individuals who are overweight. This medication, which has been shown in previous studies to reduce weight, is now being studied for its effects on reducing the occurrence of strokes, heart attacks, and other serious medical complications of obesity.

Participants enrolled in this new clinical research study receive, free of cost, either the investigational medication or placebo, medical evaluations and follow ups. Participants will also be compensated for their time. 

Participant Enrollment Criteria
  • BMI greater than or equal to 27

  • Individuals greater than or equal to 40 years of age with a diagnosis of cardiovascular disease OR

  • Women 55 and older and men ages 50 and older without cardiovascular disease but have risk factors including

    • Smoking​

    • High Cholesterol

    • Hypertension

    • Kidney Disease

  • Additional criteria apply

Participants Will Receive
  • Compensation for their time and effort

  • Investigational medication or placebo medication, blood tests and medical evaluations under the care of a physician

Location and Time
  • 5 years

  • Mix of virtual and in-person visits at ERA in Redmond, WA

If you are interested in participating in this study or have questions about your eligibility, please use the form below or contact our study recruitment team.

Interested in future studies?

Join our participant list using the link below if you are interested in becoming a study participant for other current or future studies offered by ERA.

bottom of page